| | Family Health | Men's Health
History of Meningitis Research: From Weichselbaum to Vaccines
Early meningitis research focused on identifying the causative microorganisms, understanding pathogenesis, and developing diagnostics and vaccines. The field advanced through distinct eras, each building on the last.
Key Milestones
1. Bacterial Identification (Late 19th Century)
- 1887: Anton Weichselbaum isolated Neisseria meningitidis (meningococcus) from CSF of epidemic cerebrospinal meningitis cases—proving bacterial etiology.
- 1892: Heinrich Quincke introduced lumbar puncture, enabling antemortem CSF analysis.
- 1896: Albrecht Fraenkel identified Streptococcus pneumoniae (pneumococcus) as a major cause.
- 1890s: Haemophilus influenzae (Pfeiffer’s bacillus) recognized; later found to be a major pediatric pathogen (type b).
2. Pathogenesis & CSF Dynamics
- Early 20th century: Elucidation of blood-brain barrier (BBB) disruption, cytokine storm (TNF-α, IL-1), and cortical venous thrombosis as mechanisms of neuronal injury.
- Studies on bacterial adhesion, capsule virulence factors, and immune evasion.
3. Diagnostic Advances
- Gram stain & culture: Gold standard (still).
- Latex agglutination / counterimmunoelectrophoresis (1970s): Rapid antigen detection.
- PCR (1990s+): Molecular detection of bacterial/viral DNA/RNA – faster, more sensitive, works after antibiotics.
- Biomarkers: Procalcitonin, CRP, lactate for bacterial vs. viral differentiation.
4. Vaccine Development
| Vaccine | Year Introduced | Impact |
|---|---|---|
| Polysaccharide meningococcal (A, C, W, Y) | 1970s | Short-lived immunity, no herd effect |
| Hib conjugate (PRP-T, HbOC, etc.) | 1987–1990 | >99% reduction in invasive Hib disease |
| Pneumococcal conjugate (PCV7 → PCV13 → PCV15/20) | 2000 onward | Dramatic drop in pneumococcal meningitis |
| Meningococcal conjugate (MenACWY) | 2005 | Herd immunity, adolescent routine |
| MenB (Bexsero, Trumenba) | 2014–2015 | Covers serogroup B (common in outbreaks) |